AQR Capital Management
CRVO icon

AQR Capital Management’s CervoMed CRVO Stock Holding History

AQR Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,804
Closed -$143K – 3491
2025
Q2 		$143K Sell
22,804
-2,042
-8% -$17.4K ﹤0.01% 3121
2025
Q1 		$227K Buy
+24,846
New +$94.6K ﹤0.01% 2822

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

AQR Capital Management's CRVO Position: Q3 2025 in Review

AQR Capital Management sold out of CervoMed (CRVO) in Q3 2025, closing a stake of 22,804 shares — an estimated $143K sold.

AQR Capital Management first reported a position in CRVO in Q1 2025 and held it in 2 quarters. The position peaked at $227K in Q1 2025. 45 funds tracked by Wall St. Rank hold CRVO as of Q3 2025.

  • AQR Capital Management reported no remaining CervoMed position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 22,804 CervoMed shares in Q3 2025, an estimated $143K.
  • AQR Capital Management first reported a position in CervoMed in Q1 2025 and held it in 2 quarters.
  • AQR Capital Management's CervoMed position peaked at $227K in Q1 2025.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.